text: Imaging Techniques: Options for the Diagnosis and Monitoring of Treatment of Enthesitis in Psoriatic Arthritis. J Rheumatol. 2019 Nov 01;: Authors: Bakewell C, Aydin SZ, Ranganath VK, Eder L, Kaeley GS Abstract Psoriatic arthritis (PsA) affects up to 30% of patients with psoriasis and may include musculoskeletal manifestations such as enthesitis. Enthesitis is associated with joint damage, and early detection and treatment are essential to management of the disease. Traditionally assessed by clinical examination and conventional radiography, entheseal inflammation can now be more accurately assessed earlier in the disease using techniques such as ultrasound, magnetic resonance imaging, computed tomography, and molecular imaging. However, there is little consensus on the optimum definition for diagnosing enthesitis in PsA or on the ideal scoring system for measuring response to treatment. This review aims to summarize the benefits and limitations of different imaging modalities in the assessment of enthesitis. It also proposes that adoption of standardized definitions and validation of scoring systems and imaging techniques in clinical trials will allow the efficacy of new treatment options to be assessed more accurately. PMID: 31676700 [PubMed - as supplied by publisher]
  https://www.ncbi.nlm.nih.gov/pubmed/31676700?dopt=Abstract
  Interleukin ‐17A biomarker as a predictor for detection of early axial spondyloarthritis changes in patients with psoriasis
  ConclusionOur study can imply that IL ‐17A is a valuable, useful and low‐cost biomarker in detecting early axial SpA changes in asymptomatic and nonradiographic axial SpA (nr‐axial SpA) psoriatic patients that helps early management and prevent progressive axial involvement and disabilities.
  Source: International Journal of Rheumatic Diseases - October 4, 2020 Category: Rheumatology Authors: Dalia S. Saif, Mohamed A. El Tabl, Naglaa Afifi, Mahmoud S. Abdallah, Sally M. El Hefnawy, Shimaa A. Hassanein Tags: ORIGINAL ARTICLE Source Type: research
  Publication date: Available online 2 October 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Tsen-Fang Tsai, Tsu-Yi Hsieh, Ching-Chi Chi, Chung-Tei Chou, Lin-Fen Hsieh, Hsin-Hua Chen, Rosaline Chung-Yee Hui, Chih-Hung Lee, Chin-Hsiu Liu, Hwa-Chang Liu, Kai-Jieh Yeo, Chun-Hsiung Chen, Hung-An Chen, Ying-Chou Chen, Yi-Ju Chen, Hsien-Yi Chiu, Ji-Chen Ho, Yu-Huei Huang, Po-Ju Lai, Woan-Ruoh Lee
  Source: Journal of the Formosan Medical Association - October 2, 2020 Category: General Medicine Source Type: research
  ology Association (TRA) and the Taiwanese Association for Psoriasis and Skin Immunology (TAPSI) Abstract In Taiwan, the incidence and prevalence of psoriatic arthritis (PsA) have risen significantly in recent years. Moreover, data from the Taiwan National Health Insurance Research Database (NHIRD) show that more than 85% of PsA patients are treated with just non-steroidal anti-inflammatory drugs (NSAIDs) and/or conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). Taiwanese clinicians have also expressed concerns regarding uncertainties in the diagnosis of PsA and the delayed, interrupted, and/...
  Source: J Formos Med Assoc - September 30, 2020 Category: General Medicine Authors: Tsai TF, Hsieh TY, Chi CC, Chou CT, Hsieh LF, Chen HH, Hui RC, Lee CH, Liu CH, Liu HC, Yeo KJ, Chen CH, Chen HA, Chen YC, Chen YJ, Chiu HY, Ho JC, Huang YH, Lai PJ, Lee WR, Liao HT, Lin SH, Tseng JC, Wang TS, Wu NL, Yang DH, Tsai WC, Wei JC, Taiwan Rheuma Tags: J Formos Med Assoc Source Type: research
  More News: Arthritis | Clinical Trials | CT Scan | MRI Scan | Psoriasis | Psoriatic Arthritis | Radiography | Rheumatology | Ultrasound